Clinical Trials in Georgia

Showing 2981-3000 of 14,426 trials

Omnipod 5 System Compared to Pump Therapy

NCT05409131

Subject will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 90-day outpatient phase where subjects will either use the Omnipod 5 system or continue to use their personal insulin pump with the study provided continuous glucose monitoring system. Participants in France will be offered an optional extension of 12 months of Omnipod 5 System use.

Type 1 Diabetes

Insulet Corporation196 participantsStarted Jul 2022

Palo Alto, California, United States • Santa Barbara, California, United States • Denver, Colorado, United States +11 more locations

Active Not RecruitingPhase 365 miles

Management of the PDA Trial

NCT03456336

Estimate the risks and benefits of active treatment versus expectant management of a symptomatic patent ductus arteriosus (sPDA) in premature infants.

Infant, PrematurePatent Ductus ArteriosusInfant, Newborn, Diseases+1 more

NICHD Neonatal Research Network836 participantsStarted Feb 2019

Birmingham, Alabama, United States • Palo Alto, California, United States • San Diego, California, United States +16 more locations

Omnipod 5 System Compared to Pump Therapy

Management of the PDA Trial

Find Trials by Condition in Georgia

NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)

Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children

Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus

A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic Function

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

Study of Anti-Malarials in Incomplete Lupus Erythematosus

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery

Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System

Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms

Promising ROd-cone DYstrophy Gene therapY

Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency